BEUDAMED
    FDA Adverse Event Death Summary report: Y

    AMPLATZER AMULET

    MDR report key: 25048462 · Received April 30, 2026

    Report

    Report Number
    2135147-2026-02877
    Event Type
    Death
    Date Received
    April 30, 2026
    Date of Event
    October 24, 2024
    Report Date
    April 30, 2026
    Manufacturer
    ABBOTT MEDICAL
    Product Code
    NGV
    PMA / PMN Number
    P200049
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 0

    6 EVENTS OF DEATH DUE TO RENAL WERE REPORTED IN THE CURRENT REPORTING PERIOD. A MORE COMPREHENSIVE ASSESSMENT COULD NOT BE PERFORMED AS LIMITED INFORMATION WAS PROVIDED INCLUDING THAT THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE LIMITED INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. HOWEVER, RISK ASSESSMENT WAS COMPLETED FOR THE REPORTED INCIDENTS 34 OUT OF 12,215 (0.28%) SUBJECTS EXPERIENCED RENAL SINCE THE BEGINNING OF THE REGISTRY. THE ADVERSE EVENTS AND RATES REPORTED IN THIS STUDY WERE FOUND TO BE ANTICIPATED IN THE STUDY POPULATION AND ARE IN ALIGNMENT WITH RATES OBSERVED IN OTHER CLINICAL STUDIES. NO NEW RISKS HAVE BEEN IDENTIFIED FOR THIS POPULATION. NO NEW HAZARDS OR HARMS WERE IDENTIFIED THAT WOULD IMPACT THE BENEFIT/RISK PROFILE. BASED ON A REVIEW OF THE AVAILABLE INFORMATION, THERE WAS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH REGARDS TO MANUFACTURE, DESIGN, OR LABELING. THEREFORE, NO REMEDIAL ACTION IS REQUIRED AT THIS TIME. THIS REPORT IS FOR QUARTER 1 TIMEFRAME BETWEEN 01 JANUARY 2026 - 31 MARCH 2026. B2 - DATE OF DEATH: THE EARLIEST DATE OF DEATH WAS USED B3 - DATE OF EVENT: THE EARLIEST EVENT DATE WAS USED. D4. PRIMARY UDI NUMBER: THE UDI NUMBER IS NOT KNOWN AS THE PART AND LOT NUMBER WERE NOT PROVIDED. D6A - IMPLANT DATE: THE EARLIEST IMPLANT DATE WAS USED.

    Description of Event or Problem · 0

    IT WAS REPORTED THROUGH AMULET LAAO REGISTRY DATA THAT AMPLATZER AMULET DEVICES MAY BE RELATED TO 6 RENAL WHICH ARE CONSIDERED DEATH EVENTS. THE RELATIONSHIP OF THE ADVERSE EVENTS TO THE AMPLATZER AMULET DEVICES COULD NOT BE DETERMINED BASED ON THE LIMITED DATA RECEIVED FROM THE REGISTRY. AMULET LAAO REGISTRY DATA IS REPORTED AS A SUMMARY PER SUMMARY REPORTING EXEMPTION APPROVAL NUMBER - GEN2201026. THE DATA RECEIVED INDICATED THAT THE PROCEDURE DATE RANGE WAS BETWEEN 30 MARCH 2023 - 07 DECEMBER 2023. PATIENTS¿ MEAN AGE IS 78 YEARS, RANGING FROM 68 - 87 YEARS. 67% OF THE PATIENTS WERE MALE, 33% OF THE PATIENTS WERE FEMALE. THIS REPORT IS FOR QUARTER 1 TIMEFRAME BETWEEN 01 JANUARY 2026 - 31 MARCH 2026. AS OF 20 MARCH 2026, 12,215 PATIENTS WERE TREATED WITH THE AMULET DEVICE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    189998 AMPLATZER AMULET CARDIAC PLUG NGV ABBOTT MEDICAL UNK AMPLATZER AMULET

    Patients

    Seq Age Sex Outcome Treatment
    1 78 YR Male Death